TTrialPathMatch Me to Trials
← Back to trials
RecruitingBradycardiaHeart FailureVentricular Dysfunction

Ultra-High Frequency - Electrocardiogram (UHF-ECG) for the Diagnosis of Ventricular Electrical Dyssynchrony (VED)

Eligible age

18+ yrs

Accepts

All genders

Locations

6 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The purpose of this study is to demonstrate the safety and effectiveness of the VDI UHF-ECG System in the diagnosis of ventricular dyssynchrony when compared to the 12-lead ECG in patients with bradycardia and heart failure indicated for pacemaker implantation.

Sponsor: VDI Technologies

You may qualify if…

  • Adults with bradycardia or heart failure scheduled for first time pacemaker implant (including CRT/CSP) with one of the following: Bradycardia with ventricular synchrony and QRS duration \<= 110 ms, Bradycardia with LBBB, Bradycardia with RBBB, Bradycardia with other IVCD necessitating intervention, or Heart failure with LBBB
  • Understands the nature of the study and is willing to comply with all study requirements.
  • Provides written informed consent.
  • A negative pregnancy test prior to the procedure for participants of child-bearing potential.

You may not qualify if…

  • Complete AV block (3rd-degree AV block) without a stable escape rhythm or other circumstances where there is no measurable QRS.
  • Subjects with a previous or current pacemaker or defibrillator implant.
  • Anatomical or other conditions that may make a 12-lead ECG difficult to obtain, such as an allergy to components of the ECG pads, burns, open wounds, etc.
  • Currently enrolled in another investigational device or drug trial that has not completed the active treatment phase and/or would conflict with this study.
  • Other co-morbid condition(s) that could limit the participant's ability to participate in the study or to comply with study requirements or impact the scientific integrity of the study.

Where it's recruiting

Arizona

Avondale · Mesa

Illinois

Chicago

Minnesota

Rochester

Ohio

Columbus

Texas

Houston

Virginia

Charlottesville

Source: ClinicalTrials.gov · NCT06641362 · last updated 2026-05-05

Ultra-High Frequency - Electrocardiogram (UHF-ECG) for the Diagnosis o · TrialPath